Kamada (KMDA) Cash & Equivalents (2012 - 2026)
Kamada (KMDA) reported Cash & Equivalents of $32.9 million for Q1 2026, down 56.82% on a YoY basis from $76.2 million in Q1 2025, and down 58.03% quarter-over-quarter from $78.4 million in Q4 2025.
Kamada (KMDA) Cash & Equivalents (2012 - 2026) Analysis & Trends
Kamada has reported Cash & Equivalents for 15 years, with the latest figure at $32.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents fell 56.82% year-over-year to $32.9 million; the trailing twelve-month figure through Mar 2026 stood at $32.9 million (down 56.82% YoY), and the FY2025 full-year result was $78.4 million, changed 0.0% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $32.9 million, down from $78.4 million in the prior quarter.
- The five-year high for Cash & Equivalents was $34.3 billion in Q1 2023, with the low at $22.0 million in Q1 2022.
- Historically, Cash & Equivalents has averaged $3.9 billion across 5 years, with a median of $56.5 million in 2024.
- The largest YoY upside for Cash & Equivalents was 155852.11% in 2023 against a maximum downside of 99.89% in 2023.
- Kamada's Cash & Equivalents stood at $34.3 million in 2022, then jumped by 62.42% to $55.6 million in 2023, then jumped by 40.97% to $78.4 million in 2024, then changed by 0.0% to $78.4 million in 2025, then slumped by 58.03% to $32.9 million in 2026.
- The last three Cash & Equivalents figures came in at $32.9 million (Q1 2026), $78.4 million (Q4 2025), and $78.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 222.27 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | 32.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.92 Mn |
| Dec 31, 2025 | 78.44 Mn |
| Sep 30, 2025 | 78.44 Mn |
| Jun 30, 2025 | 78.44 Mn |
| Mar 31, 2025 | 76.25 Mn |
| Dec 31, 2024 | 78.44 Mn |
| Sep 30, 2024 | 56.55 Mn |
| Jun 30, 2024 | 56.55 Mn |
| Mar 31, 2024 | 48.19 Mn |
| Dec 31, 2023 | 55.64 Mn |
| Sep 30, 2023 | 34.26 Mn |
| Jun 30, 2023 | 34.26 Mn |
| Mar 31, 2023 | 34.26 Bn |
| Dec 31, 2022 | 34.26 Mn |
| Sep 30, 2022 | 31.25 Bn |
| Jun 30, 2022 | 21.97 Mn |
| Mar 31, 2022 | 21.97 Mn |
| Dec 31, 2021 | 18.59 Mn |
| Sep 30, 2021 | 99.84 Mn |
| Jun 30, 2021 | 68.42 Mn |